Industry

Gulf states embrace stem cell technologies at home and abroad

Nadia El-Awady

Seventy years ago, the desert sands of Arabia revealed vast oil reserves. That wealth is now being put to work to fund potential new sources of revenue

Published online: 17 January 2008; doi:10.1038/stemcells.2008.21

Full Text

Stem cell therapies the old-fashioned way

Amber Dance

A biotech start-up sees stem cells as targets, not transplants

Published online: 30 December 2008; doi:10.1038/stemcells.2008.161

Full Text

In search of a viable business model

Heidi Ledford

Stem cell companies evolve to meet the demands of investors, partners and customers

Published online: 30 October 2008; doi:10.1038/stemcells.2008.138

Full Text

California institute to help stem-cell biotechs - pp436 - 437

Erika Check Hayden

Loan programme aims to support firms in getting products to the clinic.

Published online: 24 September 2008; doi:10.1038/455436b

Full Text

GlaxoSmithKline cements interest in stem cells - p564

Published online: 30 July 2008; doi:10.1038/454564c

Full Text

Stem-cell banking: lifeline or sub-prime?

Bryn Nelson

Commercial cell banks are charging high prices to store stem cells for therapeutic applications that may never be realized

Published online: 13 March 2008; doi:10.1038/stemcells.2008.48

Full Text

Stem Cells: In search of common ground - pp855 - 858

Nathan Blow

With the number of stem-cell lines rapidly increasing, technology developers are working to improve systems for culturing and efficient differentiation — all with an eye on the clinic. Nathan Blow reports.

Published online: 13 February 2008; doi:10.1038/451855a

Full Text | PDF (721 KB)

OncoMed scores drug deal for $1.4 billion with Glaxo

doi:10.1038/451511e

Full Text


Extra navigation

naturejobs